SNSS Financial Facts
Net loss: -10.45MOther income (expense), net: 23K
See Full Income Statement
Accumulated other comprehensive income (loss): 1K
Cash and cash equivalents: 9.45M
See Full Balance Sheet
Sunesis Pharmaceuticals Inc. (SNSS) Earnings
|
Expand Research on SNSS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +18.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -39.1% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/29/11 | Q410 | -$0.23 | -$0.10 | -$0.13 | N/A | N/A | N/A |  | | Details | |
| 5/12/11 | Q111 | $0.04 | -$0.14 | +$0.18 | $4M | $13K | N/A | | | Details | |
| 8/11/11 | Q211 | -$0.18 | -$0.15 | -$0.03 | N/A | $10K | N/A | | | Details | |
3/14/12  |
Q411 | -$0.19 | -$0.19 | $0.00 | N/A | $210K | N/A | | | Details | |
| 5/15/12 |
 |
Q112 | -$0.30 | -$0.18 | -$0.12 | N/A | $90K | N/A | | | Details |
| 8/9/12 |
|
Q212 | $0.20 | -$0.20 | +$0.40 | $1.5M | N/A | N/A | | | Details |
| 11/8/12 |
|
Q312 | -$0.37 | -$0.13 | -$0.24 | $265K | $4.17M | N/A | | | Details |
| 3/13/13 |
Q412 | -$0.20 | -$0.19 | -$0.01 | $1.99M | $320K | N/A | | | Details |
